Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Fluoroquinolone with bactericidal effect by inhibition of bacterial DNA synthesis. It is used topically in the form of ear drops in the treatment of otitis externa and chronic suppurative otitis media caused by susceptible strains of bacteria.
Like most ear preparations for topical use, due to its tiny dose and a low or no absorption into the blood, it is regarded as compatible while breastfeeding.
In addition, Ciprofloxacin, when it is even administered systemically, it is excreted into breast milk in very small amount without reported problems in the infants whose mothers were treated. The plasma levels in these infants were found undetectable or very low (see info on Ciprofloxacin).
The American Academy of Pediatrics states that it is usually compatible with breastfeeding. (AAP 2001)
See below the information of this related product: